Cantharidin and Its Analogues:Anticancer and Ser/Thr Protein Phosphatase Inhibitory Activities

Abstract

CLC Number:

R916.696

Supporting:

SHI Qing-hua, WANG Yu-ling, SONG Hong-rui^*, CHENG Mao-sheng. Cantharidin and Its Analogues:Anticancer and Ser/Thr Protein Phosphatase Inhibitory Activities[J]. .

[1] Wang GS. Medical uses of Mylabris in ancient China and recent studies [J]. J Ethnoparmacol, 1989, 26 : 147-162.
[2] McCluskey A, Taylor C, Quinn RJ, Inhibition of protein phosphatase 2A by cantharidin analoges [J]. Bioorg Med Chem Lett, 1996, 6 (9) : 1025-1028.
[3] Lin PY, Shi SJ, Shu HL, et al. A simple procedure for preparation of N-thiazolyl and N-thiadiazolyl cantharidinimides and evaluation of their cytotoxicities against human hepatocellular carcinoma cells [J]. Bioorg Chem, 2000, 28 (5) : 266-272.
[4] Tian SL, Zhao SW, Fang Y. Antitumor drug studies III: the synthesis and anticancer activities of norcantharidin amino acid analogues [J]. Pharm J, 1993, 28 (11) : 870-875.
[5] Li TH, Tang ZG, Huang YH. The synthesis and distribution in animals of their 125 I labeled compounds of 5, 6-dibrom-onorcantharidinimides analogues [J]. J Chin Pharm, 1999, 9 (1) : 46-47.
[6] Kawamura N, Li YM, Engel JL, et al. Endothall thioanhydride : structural aspects of unusually high mouse toxicity and specific binding site in liver [J]. Chem Res Toxicol, 1990, 3 (4) : 318-24.
[7] Kihara N, Morimoto T, Nakanishi T. Platinum-dioxolane analogue complexes as antineoplas2tics [P]. J P : 6137796, 1986-02-22.
[8] Zou FA, Dou PY, Wang K. Synthesis, antitumor activity and acute toxicity of diamine/diaminocyclohexane platinum (II) complexes with oxygen-ligating leaving group [J]. J Inorg Biochem, 1997, 65 (2) : 145-149.
[9] Li JS, Ma YQ, Liu RC, et al. Synthesis, antitumor activity and crystal structure of the triphenyltin analogue of exo-7-oxabicyclo [2. 2. 1] hept-5-ene-3-N-p-tolylamide222acid [J]. Appl Organomet Chem, 2001,15 (3) : 227-232.
[10] Lee SM, Choi WM, Syntheses and antitumor activities of medium molecular weight polymers containing α-ethoxy-exo-3,6-epoxy-1, 2, 3, 6-tetrahydrophthaloyl-5-fluorouracil [J]. J Polym Sci, Part A : Polym Chem, 1999, 37 (14) : 2619-2627.
[11] McCluskey A, Bowyer MC, Collins E, et al. Anhydride modified cantharidin analogues : synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity [J]. Bioorg Med Chem Lett, 2000, 10 (15) : 1687-1690.
[12] McCluskey A, Ackland S, Bowyer MC. Cantharidin analogues : synthesis and evaluation of growth inhibition in a panel of selected tumor cell lines [J]. Bioorg Chem, 2003, 31 : 68-79.
[13] Cohen P. The structure and regulation of protein phosphatases [J]. Annu Rev Biochem, 1989, 58 : 453-508.
[14] McCluskey A, Ackland SP, Cardiner E, et al. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design [J]. Anti Cancer Drugs Des, 2001, 16 (6) : 291-303.
[15] Ghosh S, Schroeter D, Paweletz N. Okadaic acid overrides the S-phase checkpoint and accelerates progression of G2-phase to induce premature mitosis in HeLa cells [J]. Exp Cell Res, 1996, 227 : 165-169.
[16] Roberge M, Tudan C, Hung SM, et al. Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A [J]. Cancer Res, 1994, 54 : 6115-6121.
[17] Yamashita K, Yasuda H, Pines J, et al. Okadaic acid, a potent inhibitor of type 1 and 2A protein phosphatases, acti-vates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells [J]. EMBO J, 1990, 9 : 4331-4338.
[18] Lazzereschi D, Coppa A, Mincione G, et al. The phosphatase inhibitor okadaic acid stimulates the TSH-induces G1-Sphase transition in thyroid cells [J]. Exp Cell Res, 1997, 234 : 425-433.
[19] Sassoon I, Severin FF, Andrews PD, et al. Regulation of Saccharomyces cerevisiae kinetochores by the type 1 phosphatase Glc7p [J]. Genes Dev, 1999, 13 : 545-555.
[20] Giese G, Weigers W, Kubbies M, et al. Okadaic acid co-induces vimentin expression and cell cycle arrest in MPC-11 mouse plasmacytoma cells [J]. J Cell Physiol, 1995, 163 : 145-154.
[21] McCluskey A, Keane M, Walkom C, et al. The first two cantharidin analogues displaying PP1 selectivity [J]. Bioorg Med Chem Lett, 2002, 12 : 391-393.
[22] Suzanne B, Buck CH, Satoshi I, et al. Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition [J]. J Am Chem Soc, 2003, 125 : 15694-15695.
[23] McCluskey A, Bowyer MC, Collins E, et al. Anhydride modified cantharidin analogues : synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity [J]. Bioorg Med Chem Lett, 2000, 10 (15) : 1687-1690.
[24] McCluskey A, Walkom C, Bowyer MC, et al. Cantharimides : a new class of modified cantharidin analogues inhibiting protein phosphatase 1 and 2A [J]. Bioorg Med Chem Lett, 2001, 11 (22) : 2941-2946.
[25] McCluskey A, Mirella AK, Mudgee LM, et al. Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A [J]. Eur J Med Chem, 2000, 35 : 957-964.
[26] Laidcey CW, Dauben WG, Guo IR, et al. 2-Carboxymethylendothall analogues as affinity probes for stabilized PP2A [J]. Bioorg Med Chem, 1999, 7 : 2937-2944.
[27] Gauss CM, James E, Sheppeck J E, et al. A molecular modeling analysis of the binding interactions between the okadaic acid class of natural product inhibitors and the SerPThr phosphthatases, PP1 and PP2A [J]. Bioorg Med Chem Lett, 1997, 5 (9) : 1751-1773.
[28] Baba Y, Hirukawa N, Tanohira N, et al. Structure-based design of a highly selective catalytic site directed inhibition of Ser/Thr protein phosphatase 2B [J]. J Am Chem Soc, 2003, 125 : 9740-9749.

Cantharidin and Its Analogues:Anticancer and Ser/Thr Protein Phosphatase Inhibitory Activities

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 6

Recommended Articles

Metrics

Comments

[1]	Daiying Zhou, Suqing Zhao, Xi Zheng, Zhiyun Du, Kun Zhang. Synthesis and anticancer activity study of curcumin-related compounds containing benzyl piperidone [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(8): 524-529.
[2]	Liang Guo, Wenxi Fan, Ziyun Gan, Wei Chen, Qin Ma, Rihui Cao. Design and synthesis of 1-substituted-β-carboline derivatives as potential anticancer agents [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(12): 801-808.
[3]	Qing Yang, Ji-Rang Zhu, Qi Sun^, Jing-Rong Cui, Run-Tao Li, Ze-Mei Ge^ . A novel class of cyclophosphamide prodrug: structure-activity relationships of cyclophosphamide piperaziniums [J]. , 2010, 19(1): 24-33.
[4]	ZHANG Liang, LI Hong, WU Wu-tong^*. Purification and Characterization of Cytotoxins from Agkistrodon acutus Venom and Their Anticancer Activity [J]. , 2004, 13(2): 97-102.
[5]	LI Shu-chun, LI Hui, ZHANG Fa, LI Zhong-jun^, CUI Jing-rong^^*. Anticancer Activities of Substituted Cinnamic Acid Phenethyl Esters on Human Cancer Cell Lines [J]. , 2003, 12(4): 184-187.
[6]	Liu Yingxiang, Ji Zhizhong, Mu Xiaoshuo, Zhang Baofeng . Synthesis and Anticancer Activity of (E)-4-Acyloxypropenoic Acid Derivatives [J]. , 2002, 11(3): 73-77.